Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: CES is allowing space for sex tech companies as a one-year trial. At the show, such companies were scattered throughout the health and wellness section, near startups pitching fitness trackers and infrared saunas. Lora DiCarlo, a startup that pushed for changes after organizers revoked its award, showed off its Ose robotic "personal massager." It's one of a dozen companies at the show focused on vibrators, lube dispensers and other sex tech products. Founders of these startups say their products are about empowerment and wellness for women, something they say has often been overlooked in tech. The historically male-dominated tech trade show has received criticism in past years for having an all-male lineup of speakers and for previously allowing scantily clad "booth babes," fostering a "boys' club" reputation. Besides allowing sex tech, CES organizers brought in an official "equality partner," The Female Quotient, to help ensure gender diversity. The Female Quotient, which trains companies in equality practices, will hold a conference for women during the four-day show, which opened Tuesday. "It's been a process," said Gary Shapiro, the head of the Consumer Technology Association, which puts on CES. It's been a longer process for many sex tech companies to convince investors that they are part of a growing trend that has enough customers. Much of the push has come from the startups' female founders and from younger consumers who talk more openly about sexuality. As with other technologies, some exhibitors including Lora DiCarlo had prominent booths at CES, while others such as the wearable vibrator company Crave were tucked away. Crave's exhibit included a camper with a "Build-a-Vibe-Workshop," where attendees could get an engraved vibrator to wear around their neck. Sex tech has existed in some form for decades. But the gates really began to open in 2016, said Andrea Barrica, founder of sex education site O.school. That year, several other "fem tech" companies made progress in areas such as menstruation and menopause. Those paved the way for sex tech to grow and get investors interested. "Larger institutions are starting to take note, all the way from VC firms to large Fortune 100 companies," said Barrica, who recently published the book "Sextech Revolution: The Future of Sexual Wellness." Large institutions like CES had no choice but to look at sex tech, she said. The journey hasn't been easy. Sex tech founders, many of them women, recount being turned down by dozens of investors. They faced decency arguments and entrenched corporate standards that equated them with porn. But investors are becoming more receptive, said Cindy Gallop, a former advertising executive turned sex tech entrepreneur and founder of the website MakeLoveNotPorn. "It's entirely because of our refusal to allow the business world to put us down," she said. Founders insist that their devices ranging from vibrators to lube dispensers to accessories have effects outside the bedroom. "Sexual health and wellness is health and wellness," said Lora DiCarlo, CEO and founder of the company of the same name. "It does way more than just pleasure. It's immediately connected to stress relief, to better sleep, to empowerment and confidence." DiCarlo's $290 Ose device has gotten $3 million worth of advance sales, bolstered in part by the attention it received after CES organizers overturned a decision by an independent panel of judges to give the vibrator a prestigious Innovation Honoree Award in the robotics and drone category. The organizers, CTA, told the company it reserved the right to rescind awards for devices deemed "immoral, obscene, indecent, profane or not in keeping with CTA's image." DiCarlo and other female founders pushed back for banning them but allowing humanoid sex robots meant to serve men the previous year. Following criticism, CES organizers ultimately reinstated the award and apologized. A few months later, the show announced policy changes such as a dress code to prevent skimpy outfits and new "Innovation for All" sessions with senior diversity officials. Ose began shipping to customers this month. DiCarlo said the company is planning to introduce new devices, including less expensive options. Sex tech companies still face major barriers to growth. Polly Rodriguez, CEO of sexual wellness company Unbound, said the company is profitable and customers are more open about buying products than they once were. But she said she still faces roadblocks advertising on social media, and many traditional investors snub the company. "Things are better, but there's just still this genuine fear of female sexuality more broadly within the institutional side of technology," she said. And while Gallop offered to speak at CES, conference organizers declined, saying sex tech was not a part of its conference programming. ___ AP Business Writer Joseph Pisani contributed to this report. ___ AP's CES coverage: https://apnews.com/Consumerelectronics
Example Output: Sex tech from women-led startups pops up at CES gadget show.

Example Input: The story does not describe the costs of uterine artery embolization or how they compare to costs of surgery. The cost of UAE is quite high and for some women may not be covered by insurance. The story provides adequate quantification of some of the most important things for consumers to know, such as the fact that after a year, there were no differences in the quality of life of the women assigned to uterine artery embolization compared to those assigned to surgery and that 13% of those who underwent UAEhad a repeat hospitalization, mostlyfor surgical intervention because of failure of UAE to achieve the desired results. The story could have provided more quantification of other pieces of information that women would want to know, such as length of hospital stay, time to return to work, or risk of serious adverse events. The story does mention some of the potential harms of uterine artery embolization, such as the need for repeat procedures for treatment of recurrent symptoms and the fact that there are questions aboutsafety of pregnancy after the procedure. The story should have also mentioned the potential for ovarian failure, causing infertility, infection, delayed complications and a small risk of emergency hysterectomy. The story adequately describes the design of the current study. The story accurately describes the prevalence and symptoms of uterine fibroids. The story only uses quotes from the original article and accompanying editorial. It doesn't appear that the authors were even interviewed. The story should have quoted other clinicians/researchers who were not related to the study who could have provided some perspective on what this new information means for clinical practice. The story does mention alternative options such as myomectomy (surgical removal of the fibroids), hysterectomy (surgical removal of the uterus) in addition to uterine artery embolization. The story could have mentioned other treatments such as watchful waiting, pain medications orbirth control pills. The story does not state whether uterine artery embolization (UAE) is available and if so, how widely. And availability is a real issue. It requires expertise in interventional vascular radiology and an interest in the female pelvic anatomy. Facilities offering the procedure would need strong links between gynecologists and radiologists to provide coordinated assessment and care. This is not explained in the piece. The story implies that uterine artery embolization is a new procedure. The story could have mentioned that the procedure has been performed for more than 10 years in Europe and the US, although it has been limited to mostly academic hospitals. There is no way to know if the story relied on a press release as the sole source of information, although it is noteworthy that the story only uses quotes lifted from the published study and from an accompanying editorial. It doesn't appear that these people were actually interviewed.
Example Output: Treating fibroids without surgery

Example Input: Business by its very nature is cut-throat; competitors rarely aid one another because one company's success almost invariably comes at the expense of the other's vitality. When such leg-ups occur, they are often inadvertent the result of one firm's having failed to take advantage of an opportunity that its competitor later cleaned up on. Such was the case when Mars, Inc. passed on the chance for its flagship product, M&Ms, to be the candy used in 1982 film E.T. the Extra-Terrestrial. Its turn-down cleared the way for Hershey Foods Corporation to make a remarkable splash for its Reese's Pieces. During production of E.T., Amblin Productions approached Mars, Inc. about a possible tie-in between M&Ms and the film. For whatever reason, Mars said "No" to the proposition. Many purported reasons for that negative response have been provided by a variety of sources: Mars decided it didn't want its bite-size candy associated with an extraterrestrial living with an earth family, or it thought the film's premise just a bit too otherworldly, or an unnamed M&M executive decided nobody would want to see a movie about an alien adopted by a lonely kid. (M&Ms did survive as the candy used in the 1982 William Kotzwinkle novelization of the film, however.) Lore adds its own details to flesh out stories, details that will cast the one who is perceived as having done something foolish in as absurd a light as possible. When that story is one of a poor business decision made by a large corporation, someone telling the tale is sure to state as rock-solid fact an explanation that is now clearly laughable. No one ever suggests that Mars might have already had its advertising budget locked for that year, or that it might have felt ill at ease at the prospect of dealing with a new advertising medium and the new people who went with it, or any other plausible and purely logical business reason for taking a pass on this offer. No, the "reason" offered in lore will always be something along the lines of "Mars didn't think much of the planned movie and thus wanted to keep themselves separate from it," a "reason" that casts the candymaker as unbelievably short-sighted given the breathtaking success of E.T. Whatever the reason for it, Mars' "No" paved the way for Hershey's "Yes." The spurned offer was then tendered to Hershey, and misgivings aside that corporation went for it. Hershey did not pay to have Reese's Pieces used in E.T., but it did agree to do a tie-in between the movie and the candy after the film was released. A deal was inked wherein Hershey Foods agreed to promote E.T. with $1 million of advertising; in return, Hershey could use E.T. in its own ads. Within two weeks of the movie's premiere, Reese's Pieces sales went through the roof. (Disagreement exists as to how far through the roof they went: Sales were variously described as having tripled, experienced an 85% jump, or increased by 65%). Whatever the numbers, though, Reese's Pieces up until then an underdog confection only faintly known by the U.S. candy-consuming public were suddenly being consumed in great handfuls. And all thanks to a shy little alien lured from the bushes and into America's hearts by a trail of peanut-butter-in-a-candy-coated-shell confections. Thus is the potential power of product placement. When it's done right, it can make a product. Paid product placement in films has come to be one of the ordinary ways of things in Hollywood. Exxon paid $300,000 for its name to appear in Days of Thunder, Pampers paid $50,000 to be featured in Three Men and a Baby, and Cuervo Gold spent $150,000 for placement in Tequila Sunrise, according to Danny Thompson, president of Creative Entertainment Services, in a 1993 New York magazine interview. As for how effective the practice of product placement is, that same article quotes Joel Henrie, a partner at Motion Picture Placement, as saying: "Look what happened to Hermes scarves after Basic Instinct, Ray-Ban sunglasses after Risky Business, and suspenders after Michael Douglas wore them in Wall Street." Not all product placement deals are "straight-fee" arrangements. There are actually three types of deals, the other two being the provision of costly merchandise (such as automobiles or appliances) for free just for the exposure (which accounts for about half of all placements), and the back-end promotion under which big corporations with huge promotional budgets aim for young audiences through tie-ins with popular films. In most films, product placement, while noticeable, is kept low-key. However, some Hollywood offerings have gone down in the annals of motion picture history as notorious examples of rampant commercialism. The 1988 snoozer Mac and Me could fairly be described as a ninety-minute advert for McDonald's and Coca-Cola, with an alien thrown in whenever things were running slow. Likewise, the 1987 film Leonard Part 6 was deemed by many to be a never-ending Coca-Cola commercial. But rampant product placement is not merely limited to forgettable films which did poorly at the box office, as 1999's Runaway Bride proved. (In that film, everyone walks around with a copy of USA Today in his hands.) Product placement in movies is now a corporate fact of life, as are "bonehead" accounts of great marketing opportunities left to the other guy. One company's gaffe becomes the cautionary tale passed along to those in all manner of industries because the message is universal: This could be us one day if we don't maintain vigilance. Once again, folklore is called upon to teach by example what might not have effectively been learned from a book. In an odd way, true-life corporate instances of one man's garbage turning out to be another man's treasure are almost a rip on the standard Hollywood legend of (pick your favorite movie star) was offered the lead in (now unforgettable, hugely-popular film) but turned it down. Though that scenario has indeed played out a number of times in Tinseltown, it hasn't happened nearly as often as is reported. In many cases, remembered tidbits of so-and-so's having been mentioned merely in passing at a studio round-table of "Who could we get?" are mentally embroidered into memories of the role's having been offered to the star, who waved it away. Or a bit of rumor is later remembered as fact, such as the case of Ronald Reagan, whose name was only kited as part of a press release designed to drum up interest in Casablanca but is now widely believed to have been the studio's first choice to play Rick Blaine a role never intended for anyone but Humphrey Bogart.
Example Output:
M&Ms passed up the chance to be the candy used to lure the shy little alien from his hiding place in the 1982 blockbuster E.T., thereby letting one of the most successful instances of movie product placement fall into the hands of a competitor who benefited mightily from it.